Olon Expands API Production

Olon, an Italian CDMO and API producer, is investing a total of €100 million in 2023 to increase production capacity, in particular at its site in Mulazzano, Lodi province.

As part of the investment, Olon is installing a new mill for grinding finished APIs, which the company said will lift productivity and ensure high particle size standards. “We expect a significant increase in the potential capacity of the site,” said head of global operations Marcello Buson.

In February this year, Olon announced that it had completed a project at its facility in Rodano, Milan, that expanded pilot plant capacity for scaling up highly active APIs. The company has other pilot plants for developing high-potency APIs with which the Rodano plant will be integrated for increased capacity and improved flexibility.

Olon said the investment at Rodano is part of its strategy to implement a highly integrated operating model between both R&D and manufacturing operations, as well as the integration of specific, highly specialized processes consolidated within research and development centers located at sites around the world.

The integration will also be applied to product scale-up projects, which Olon said require the transition from pilot scale to large- and very large-scale production plants that have similar equipment so as to ensure the same level of containment, even for large batch sizes.

Author: Elaine Burridge, Freelance Journalist

Company

Logo:

Olon S.p.A.

Strada Rivoltana, Km 6/7
20053 Rodano (MI)
Italy

Company contact







Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.